checkAd

    DGAP-News  160  0 Kommentare MEDIQON Group AG: Conclusion of an Investment Agreement

    DGAP-News: MEDIQON Group AG / Key word(s): Capital Increase
    MEDIQON Group AG: Conclusion of an Investment Agreement

    04.11.2021 / 18:33
    The issuer is solely responsible for the content of this announcement.


    MEDIQON Group AG: Conclusion of an Investment Agreement

    As announced in the 04/11/2021, 18.20 ad-hoc notice, management and supervisory boards of MEDIQON Group AG have resolved on a 10% cash capital increase from authorized capital (up to 999,955 shares) today. In addition, it was decided to start preparations of an additional capital increase via rights issue for 3,999,824 shares, most likely to take place in 2022.

    In the context of both capital increases, MEDIQON concluded an Investment Agreement with a group of institutional investors.

    Sator Grove Holdings LLC as Lead-Investor and three other renowned institutional investors intend to invest more than EUR 40 million cumulated in both capital increases. In particular, the Investment Agreement relates to the placement of any possible share overhang in the forthcoming 2022 rights issue.

    It is intended to set the subscription price of the 2022 rights issue with a similar logic as the price of today's placement, while also incorporating the operating development of MEDIQON's platform companies.

    Jan-Hendrik Mohr, CEO of MEDIQON Group AG:

    "We are delighted to receive such great support from institutional investors to further enhance the growth of MEDIQON. The team at Sator Grove has long experience investing in decentralized holding companies in general and vertical market software in particular. Additionally, Sator Grove brings both a permanent capital structure and strategic shareholder base that stands out across today's institutional landscape. We are now set with optimal resources to help scale the platform companies of MEDIQON for many years to come!"

    Paul Buser, Co-Founder and Co-CEO, Sator Grove Holdings LLC:

    "We are thrilled to be able to come alongside MEDIQON at this inflection point in the company's trajectory. Jan and his team have a proven track record and are now superbly positioned to add value to all stakeholders and to be the most desired home for high quality businesses across Germany and beyond!"

    Seite 1 von 3


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-News MEDIQON Group AG: Conclusion of an Investment Agreement DGAP-News: MEDIQON Group AG / Key word(s): Capital Increase MEDIQON Group AG: Conclusion of an Investment Agreement 04.11.2021 / 18:33 The issuer is solely responsible for the content of this announcement. MEDIQON Group AG: Conclusion of an …

    Schreibe Deinen Kommentar

    Disclaimer